8-K
filed July 1, 2025, 7:59 PM ET
ticker OCGN
CIK 0001372299
regulatory
confidence high
sentiment neutral
materiality 0.50
Ocugen receives Nasdaq extension to Dec 29, 2025 to meet $1 bid price requirement
Ocugen, Inc.
- Ocugen granted 180-day extension until Dec 29, 2025 to regain compliance with Nasdaq minimum bid price $1.00.
- Previously, on Dec 31, 2024, Nasdaq warned that stock had traded below $1 for 30 consecutive business days.
- If bid price closes at $1.00 or more for 10 consecutive business days before Dec 29, compliance will be achieved.
- Failure to demonstrate compliance by Dec 29 may result in delisting, subject to possible appeal to Nasdaq Hearing Panel.
- No assurance that appeal would succeed if delisting is determined.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001104659-25-064695
- form_type
- 8-K
- ticker
- OCGN
- cik
- 0001372299
- company_name
- Ocugen, Inc.
- filed_at
- 2025-07-01T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:43.832513+00:00
- generated_at
- 2026-05-18T09:55:51.579964+00:00
- sec_items
- ["3.01"]
- event_type
- regulatory
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001104659-25-064695
- json_url
- https://secwatch.observer/filing/0001104659-25-064695.json
- markdown_url
- https://secwatch.observer/filing/0001104659-25-064695.md
- text_url
- https://secwatch.observer/filing/0001104659-25-064695.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1372299/000110465925064695/0001104659-25-064695-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1372299/000110465925064695/tm2519606d1_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
XXI
Twenty One Capital receives NYSE non-compliance notice; audit committee lacks independence; cure due June 5
Twenty One Capital, Inc.
June 1, 2026, 7:05 AM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
cator
and website references will be removed when the Company regains compliance with all NYSE quantitative and corporate governance listing
standards. The Company expects to appoint, as soon as practicable, an additional member to the audit committee who meets the independence
requirements of Rule 10A-3 under the Securities Exchange Act of 1934, as amended, and Section 303A.02 of the Listed Company Manual. Forward-Looking Statements Certain statements in this periodic report are “forward-looking
statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words indi
Filing page
SEC filing
COLA
Columbus Acquisition regains compliance with Nasdaq $50M MVLS rule; delisting risk removed
Columbus Acquisition Corp/Cayman Islands
May 29, 2026, 9:56 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
May 28, 2026, the Company the Company received a written notice from Nasdaq notifying the Company that the Staff has determined that
for the last 10 consecutive business days, from May 13, 2026 to May 27, 2026, the Company’s MVLS has been $50 million or greater.
Accordingly, the Company has regained compliance with the MVLS Rule and the Staff has indicated that the matter is now closed. 1 SIGNATURES Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized. Columbus
Acq
Filing page
SEC filing
CETY
Clean Energy Technologies receives Nasdaq delisting notice for late Q1 filing
Clean Energy Technologies, Inc.
May 29, 2026, 4:57 PM ET
regulatory
Items 3.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
May 26, 2026, Clean Energy Technologies, Inc. (the “ Company ”) received a written notice (the “ Notice ”)
from the Listing Qualifications Department of The Nasdaq Stock Market (“ Nasdaq ”) indicating that the Company is not
in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”) because the Company had not yet filed its Quarterly
Report on Form 10-Q for the period ended March 31, 2026 (the “ Quarterly Report ”). The
Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has
no immediate effect on the listing
Filing page
SEC filing
FTHM
Fathom Holdings receives Nasdaq notice for late Q1 2026 10-Q filing; 60 days to submit plan
Fathom Holdings Inc.
May 29, 2026, 4:15 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
May 22, 2026, Fathom Holdings Inc. (the “Company”) received a notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that, because the Company has not yet filed its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Form 10-Q”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of all required periodic financial reports with the Securities and Exchange Commission (the “Filing Requirement”). In accordance with Nasdaq’s listing rules, the Company has 60 calendar days from the date of the notification letter
Filing page
SEC filing
LASE
Laser Photonics receives Nasdaq delisting notice for late Q1 2026 10-Q
Laser Photonics Corp
May 22, 2026, 5:27 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
received a notice from Nasdaq Listing Qualifications
department of the Nasdaq Stock Market LLC (“Nasdaq”) stating that since it had not received the Company’s Form 10-Q
for the period ended March 31, 2026, the Company does not comply with Nasdaq’s Listing Rules for continued listing. Nasdaq stated
that the Company has 60 days to submit a plan to regain compliance with respect to this delinquent report. Nasdaq can grant an exception
to allow the Company to regain compliance up to a maximum of 180 calendar days from the due date of the Initial Delinquent Filing, or
November 16, 2026. A
copy of t
Filing page
SEC filing
RICK
RCI receives Nasdaq noncompliance notice for late Q2 10-Q; deadline July 20
RCI HOSPITALITY HOLDINGS, INC.
May 22, 2026, 4:23 PM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
May 20, 2026, RCI Hospitality Holdings, Inc. (“we,” “us” and the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) indicating that we are
Filing page
SEC filing
AVXL
Anavex receives Nasdaq delinquency notice for late 10-Q filing; deadline July 20, 2026
ANAVEX LIFE SCIENCES CORP.
May 22, 2026, 8:15 AM ET
regulatory
Items 3.01, 8.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
May 20, 2026, Anavex Life Sciences Corp. (the “Company”)
received a delinquency notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market
LLC (“Nasdaq”) indicating that, as
Filing page
SEC filing
GTBP
GT Biopharma receives Nasdaq extension to Nov 16, 2026 to meet $1 minimum bid price
GT Biopharma, Inc.
May 22, 2026, 8:00 AM ET
regulatory
Items 3.01, 9.01
same fact type: exchange_compliance_notice
same SEC item: 3.01
same event type: regulatory
similar materiality
This filing
July 1, 2025, Ocugen, Inc.
(the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”)
of the Nasdaq Stock Market (“Nasdaq”) that the Company has been granted an additional 180 calendar days, or until December
29, 2025, to regain compliance with the minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”)
as required by Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. As previously reported, on
December 31, 2024, Nasdaq notified the Company that for the last 30 consecutive business
Comparable filing
May 20, 2026, GT Biopharma, Inc., a Delaware corporation (the “Company”), received a letter from the Nasdaq Listing Qualifications
Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.